Bliss GVS Pharma Limited (NSE:BLISSGVS)

Bliss GVS Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	-	231.4	249.55	219.15	126.35	150.89
Short-Term Investments	-	1,167	384.44	1,130	490.29	246.3
Trading Asset Securities	-	5.57	49.6	-	-	-
Cash & Short-Term Investments	2,198	1,404	683.59	1,349	616.64	397.19
Cash Growth	34.93%	105.34%	-49.34%	118.83%	55.25%	-54.27%
Accounts Receivable	-	4,043	3,852	3,928	4,638	5,479
Other Receivables	-	134.02	57.8	119.38	170.47	251.45
Receivables	-	4,178	3,910	4,048	4,810	5,732
Inventory	-	1,184	1,031	1,239	989.27	741.38
Prepaid Expenses	-	27.76	24.21	31.9	14.32	16.55
Other Current Assets	-	1,322	1,325	1,100	1,222	809.94
Total Current Assets	-	8,116	6,974	7,769	7,652	7,697
Property, Plant & Equipment	-	3,694	3,729	2,948	2,278	2,326
Long-Term Investments	-	80.2	568.59	36.75	620.13	10.25
Goodwill	-	77.11	77.11	77.11	77.11	77.11
Other Intangible Assets	-	1.07	2.29	3.83	5.79	6.42
Long-Term Deferred Tax Assets	-	-	33.33	-	-	-
Other Long-Term Assets	-	170.32	184.42	252.93	134.35	135.16
Total Assets	-	12,139	11,569	11,087	10,768	10,272
Accounts Payable	-	609.65	863.9	926.06	742.25	899.17
Accrued Expenses	-	59.43	55.09	47.86	50.93	30.43
Short-Term Debt	-	324.17	460.14	607.03	650.38	663.85
Current Portion of Long-Term Debt	-	197.98	113.63	210.32	211.11	173.4
Current Portion of Leases	-	27.55	11.14	9.42	13.18	21.88
Current Income Taxes Payable	-	18.66	26.56	66.49	86.01	98.61
Current Unearned Revenue	-	69.24	34.7	90.08	157.91	232.22
Other Current Liabilities	-	291.53	367.44	373.6	124.59	185.71
Total Current Liabilities	-	1,598	1,933	2,331	2,036	2,305
Long-Term Debt	-	355.92	406.9	232.22	326.04	372.39
Long-Term Leases	-	92.79	27.17	34.92	18.29	29.74
Long-Term Unearned Revenue	-	0.61	0.74	0.87	1.01	1.14
Long-Term Deferred Tax Liabilities	-	35.93	-	13.23	82.09	35.55
Total Liabilities	-	2,109	2,394	2,623	2,489	2,768
Common Stock	-	104.69	104.15	103.68	103.15	103.15
Additional Paid-In Capital	-	331.64	269.94	212.77	147.57	147.57
Retained Earnings	-	9,324	8,603	7,941	7,826	7,188
Comprehensive Income & Other	-	-88.46	-138.53	-70.73	5.38	-82.45
Total Common Equity	10,099	9,672	8,839	8,187	8,083	7,356
Minority Interest	-	357.9	335.27	277.6	196.56	147.59
Shareholders' Equity	10,480	10,030	9,174	8,465	8,279	7,504
Total Liabilities & Equity	-	12,139	11,569	11,087	10,768	10,272
Total Debt	941.72	998.4	1,019	1,094	1,219	1,261
Net Cash (Debt)	1,257	405.27	-335.39	255.5	-602.36	-864.07
Net Cash Per Share	11.86	3.82	-3.18	2.43	-5.71	-8.38
Filing Date Shares Outstanding	104.86	104.69	104.15	103.68	103.36	103.15
Total Common Shares Outstanding	104.86	104.69	104.15	103.68	103.15	103.15
Working Capital	-	6,518	5,041	5,438	5,616	5,392
Book Value Per Share	96.16	92.39	84.87	78.97	78.36	71.32
Tangible Book Value	10,020	9,594	8,760	8,106	8,000	7,273
Tangible Book Value Per Share	95.40	91.64	84.10	78.19	77.56	70.51
Land	-	409.88	419.83	420.09	144.14	144.5
Buildings	-	1,369	1,437	1,059	1,055	1,012
Machinery	-	2,616	2,580	1,809	1,490	1,441
Construction In Progress	-	78.27	28.01	221.55	23.95	-

Source: S&P Capital IQ. Standard template. Financial Sources.